Sign In
Buy NVO
$47.42
+1.52 (+3.31%)
At Close: Jun 23, 2026
Stock Market Today: Futures Plunge as Oil Tops $100/Barrel; Treasury Yields Jump on Stagflation Fears; Dollar Strengthens
09:00am, Monday, 09'th Mar 2026
Stock futures tumbled and Treasury yields jumped as the price of oil surpassed $100 a barrel Monday, as investors fretted that the ongoing Iran war could slow the U.S. economy.
Hims & Hers shares surge 50% after Novo Nordisk ends legal feud over compounded weight loss drugs
08:52am, Monday, 09'th Mar 2026
"We have decided to drop the current court proceedings," Novo CEO Mike Doustdar told CNBC on Monday, however, reserving the right to bring it back "if needed." It comes after an agreement between Novo
Novo Nordisk strikes deal for Hims to sell Wegovy and Ozempic, drops lawsuit
08:33am, Monday, 09'th Mar 2026
Novo Nordisk has agreed to sell its blockbuster Wegovy and Ozempic drugs through U.S. telehealth company Hims & Hers' platform, the Danish drugmaker said on Monday, ending a legal dispute that erup
Hims & Hers, Novo Nordisk Weight-Loss Drug Deal Ends Legal Feud, Stock Soars
07:04am, Monday, 09'th Mar 2026
Novo Nordisk has decided to sell its weight-loss drug through Hims & Hers' telehealth platform, following a lawsuit over patent violations regarding a compounded version of semaglutide products.
Novo Nordisk A/S - share repurchase programme
06:39am, Monday, 09'th Mar 2026
Bagsværd, Denmark, 9 March 2026 – On 4 February 2026, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Coun
Hims shares jump after report of Novo Nordisk partnership that may end legal feud
06:33am, Monday, 09'th Mar 2026
Hims & Hers' shares were up over 50% in premarket trading on Monday following reports Novo Nordisk plans to sell its weight-loss drugs on the telehealth firm's platform, signaling a potential en
Hims & Hers Stock Soars 54%. It's Struck a Truce With Novo Nordisk, Report Says.
06:33am, Monday, 09'th Mar 2026
Novo has agreed to sell its weight-loss drugs on Hims' platform, according to a report.
Lisata Therapeutics shares up 20% as Kuva Labs acquisition advances
06:29am, Monday, 09'th Mar 2026
Lisata Therapeutics Inc (NASDAQ:LSTA, FRA:8NE), a clinical-stage pharmaceutical company developing therapies to treat advanced solid tumors and other...
Hims & Hers stock rockets on reported end to Novo Nordisk weight-loss drug dispute
05:45am, Monday, 09'th Mar 2026
Hims & Hers shares jumped nearly 50% in premarket trade on Monday after a report it has ended a dispute with Novo Nordisk by striking a partnership with the Danish drug giant.
Better Weight Loss Stock: Novo Nordisk Vs. Amgen
02:30pm, Sunday, 08'th Mar 2026
Novo Nordisk is a top player in the weight loss market and has several more products on the way. Amgen's most advanced candidate in this space could earn approval in the coming years.
Novo Nordisk A/S $NVO Shares Sold by Cresset Asset Management LLC
05:36am, Sunday, 08'th Mar 2026
Cresset Asset Management LLC decreased its position in shares of Novo Nordisk A/S (NYSE: NVO) by 24.0% during the undefined quarter, according to its most recent filing with the Securities and Exchang
Can This Next-Gen Obesity Drug Save Novo Nordisk?
10:30am, Saturday, 07'th Mar 2026
Novo Nordisk is losing to Eli Lilly in the fiercely competitive weight loss market. But one of the company's mid-stage assets could help it remain a key player.
Novo Nordisk And Hims & Hers End Bitter Legal Feud With Surprise Weight-Loss Drug Deal: Report
09:52pm, Friday, 06'th Mar 2026
Novo Nordisk and Hims and Hers Health have reportedly ended their legal feud and are preparing a new partnership to sell Novo's weight-loss drugs on the telehealth platform, surprising investors and s
Down but Not Out: Is Novo Nordisk a Conditional Buy as Eli Lilly Leads the GLP‑1 Market?
06:05pm, Friday, 06'th Mar 2026
Novo Nordisk shares look cheap, but execution and management changes weigh on investor confidence. Eli Lilly's stronger GLP-1 growth and consistency support its premium versus Novo's conditional value
Novo Nordisk A/S (NVO) Is a Trending Stock: Facts to Know Before Betting on It
10:00am, Friday, 06'th Mar 2026
Novo Nordisk (NVO) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
